First-pass extracted concept

RNA editing

Candidate: concept label2 source documents2 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

We examine therapeutic applications spanning... RNA editing...

Evidence 1Source 1DOI PubMedprovenance

Nanomedicine-enhanced delivery of CRISPR-Cas13 for RNA editing in C9orf72-associated ALS.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1review2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1application scopesupports2025Source 1DOI PubMed

Therapeutic applications discussed in the review span nuclear genome editing, mitochondrial genome modification, RNA editing, and epigenetic modulation, indicating expansion beyond traditional monogenic disorders.

Claim 2paper topicsupports2025Source 2DOI PubMed

The source concerns nanomedicine-enhanced delivery of CRISPR-Cas13 for RNA editing in C9orf72-associated ALS.